Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
autoimmune disease
Biotech
Rome nears end of road with planned layoffs, strategic review
Rome currently employs 14 people, and a yet to be determined number of them will be laid off at the end of the quarter, a spokesperson said.
Darren Incorvaia
Sep 23, 2025 2:00pm
Roivant reports phase 3 autoimmune win for ex-Pfizer asset
Sep 17, 2025 7:00am
Odyssey saga continues with $213M series D
Sep 10, 2025 8:00am
Royalty bestows Zenas with $300M for autoimmune approval push
Sep 2, 2025 11:07am
Vertex boosts artillery with $2B-plus Enlaza pact
Sep 2, 2025 10:26am
Expedition inks $645M Fosun deal to bring China asset to US
Aug 11, 2025 11:06am